Open AccessA Phase I Study of Visilizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Severe Steroid-Refractory Ulcerative Colitis
Author(s) -
Scott E. Plevy,
Bruce Salzberg,
Gert Van Assche,
Miguel Regueiro,
Daniël W. Hommes,
William J. Sandborn,
Stephen B. Hanauer,
Stephan R. Targan,
Lloyd Mayer,
Uma Mahadevan,
Matthew Frankel,
James N. Lowder
Publication year - 2007
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/g98r-2070
Subject(s) - ulcerative colitis , refractory (planetary science) , medicine , monoclonal antibody , monoclonal , antibody , colitis , immunology , biology , disease , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom